Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutchs pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nations first cancer prevention research program, as well as the clinical coordinating center of the Womens Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.
At Fred Hutch, we believe that the innovation, collaboration, and rigor that result from diversity and inclusion are critical to our mission of eliminating cancer and related diseases. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an antiracist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, antiracism, and inclusion.
The Health and Behavioral Innovations in Technology (HABIT) Group, led by Dr. Jonathan Bricker, is part of the Cancer Prevention Program in the Division of Public Health Sciences at the Fred Hutchinson. Funded by multiple large R01-level NIH grants from the NCI and NIDDK ($25 million USD cumulative total to date), the Groups research mission is to develop and rigorously test behavioral interventions for tobacco cessation and weight loss health and disseminate them with the goal of high public health impact. Technologies for delivering these interventions include smartphone applications, chatbots, websites, and telephone counseling. One of the behavioral approaches the Group has been testing is called Acceptance & Commitment Therapy (ACT). The HABIT Group is committed to increasing the diversity of future scientists passionate about research devoted to scaling behavioral principles for public health impact.
Under the mentorship of Dr. Bricker, a Full Professor, and one of the HABIT Groups Staff Scientists, Dr. Margarita Santiago-Torres, the Post-Doctoral Research Fellow will lead and co-author multiple scientific research papers and conduct original research that is part of the ongoing research from any one of our three current NIH R01 Phase III clinical trials. Regarding scientific research papers, the Fellow will be mentored in writing papers and presenting results at scientific national and international conferences. The Fellow will have access to existing data from large, randomized NIH R01 Phase III trials on tobacco cessation conducted by the HABIT Group. Existing data will include the recently published iCanQuit study (JAMA IM, 2020) of a smartphone application proven efficacious for smoking cessation. The Fellow with receive full support from the HABIT Groups biostatistician as well as training in clinical trial design, analyses of outcomes and mechanisms of action. The HABIT Groups administrators will provide support for manuscript preparation and submission.
Regarding conduct of original research, the Fellow will be mentored in proposing a 2 to 3 year NIH Diversity Supplement grant (NCI or NIDDK) for a research project that will be an integral part of the ongoing research of one of our three current R01 Phase III clinical trials. A Diversity Supplement grant will contribute significantly to the health research career development of the Fellow. The Groups three NIH R01 Phase III current trials focus on testing the efficacy of (1) an artificial intelligence chatbot for cigarette smoking cessation, (2) a smartphone application to help cancer patients stop cigarette smoking, and (3) telephone coach-delivered Acceptance and Commitment Therapy for weight loss. The Fellow will receive ongoing mentoring in the Diversity Supplement research project, interact with the Group and collaborators on the selected clinical trial, contribute intellectually to the research, and enhance research skills and knowledge in tobacco cessation, obesity, behavioral science, and delivery of digital interventions.
Summary of Responsibilities:
Write peer reviewed publications from our existing trial data (lead & co-author)
Give national and international research presentations
Submit an NIH Diversity Supplement for a mentored research project
Funded by the NIH Diversity Supplement, conduct a research project that is integral to one of our ongoing NIH funded trials.
To be considered, the successful candidate must:
Hold a doctoral degree in psychology, behavioral sciences, public health or related field
Have a track record in smoking cessation or obesity research
Have at least one first-authored publication on the topic of smoking cessation or obesity
Have excellent written and verbal communication skills
Demonstrate ability to work well within interdisciplinary teams and collaborations
Provide a diversity statement
Position duration will depend on Diversity Supplement funding. The first year of funding is guaranteed. If the Diversity Supplement is funded, the position will last a total of 2-3 years depending on the duration of the Diversity Supplement research proposed.
Fred Hutch has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations. As a condition of employment, newly hired employees must provide proof of vaccination or initiate the accommodations process before their first day of employment.
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and anti-racism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at email@example.com or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.